132 related articles for article (PubMed ID: 37151006)
1. [Characteristics of primary ocular symptoms in children with optic pathway glioma at different ages].
Mijiti G; Shi W; Li L; Yu JF; Ge M; Yan HG; Peng CX
Zhonghua Yan Ke Za Zhi; 2023 May; 59(5):376-380. PubMed ID: 37151006
[No Abstract] [Full Text] [Related]
2. Optic glioma warranting treatment in children.
Kaufman LM; Doroftei O
Eye (Lond); 2006 Oct; 20(10):1149-64. PubMed ID: 17019413
[TBL] [Abstract][Full Text] [Related]
3. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?
Aquilina K; Daniels DJ; Spoudeas H; Phipps K; Gan HW; Boop FA
Childs Nerv Syst; 2015 Nov; 31(11):2041-9. PubMed ID: 26277358
[TBL] [Abstract][Full Text] [Related]
4. Application of diffusion tensor tractography in pediatric optic pathway glioma.
Lober RM; Guzman R; Cheshier SH; Fredrick DR; Edwards MS; Yeom KW
J Neurosurg Pediatr; 2012 Oct; 10(4):273-80. PubMed ID: 22900485
[TBL] [Abstract][Full Text] [Related]
5. The role of surgery in optic pathway/hypothalamic gliomas in children.
Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C
J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145
[TBL] [Abstract][Full Text] [Related]
6. Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.
Henning AM; Handrup MM; Kjeldsen SM; Larsen DA; Ejerskov C
Orphanet J Rare Dis; 2021 Nov; 16(1):489. PubMed ID: 34809690
[TBL] [Abstract][Full Text] [Related]
7. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
8. Prechiasmatic transection of the optic nerve in optic nerve glioma: technical description and surgical outcome.
Borghei-Razavi H; Shibao S; Schick U
Neurosurg Rev; 2017 Jan; 40(1):135-141. PubMed ID: 27230830
[TBL] [Abstract][Full Text] [Related]
9. Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis.
Kornreich L; Blaser S; Schwarz M; Shuper A; Vishne TH; Cohen IJ; Faingold R; Michovitz S; Koplewitz B; Horev G
AJNR Am J Neuroradiol; 2001; 22(10):1963-9. PubMed ID: 11733333
[TBL] [Abstract][Full Text] [Related]
10. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Strabismus Among Children With Neurofibromatosis Type 1 Disease With and Without Optic Pathway Glioma.
Dotan G; Qureshi HM; Toledano-Alhadef H; Azem N; Yahalom C
J Pediatr Ophthalmol Strabismus; 2019 Jan; 56(1):19-22. PubMed ID: 30371910
[TBL] [Abstract][Full Text] [Related]
12. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
[TBL] [Abstract][Full Text] [Related]
14. Handheld optical coherence tomography during sedation in young children with optic pathway gliomas.
Avery RA; Hwang EI; Ishikawa H; Acosta MT; Hutcheson KA; Santos D; Zand DJ; Kilburn LB; Rosenbaum KN; Rood BR; Schuman JS; Packer RJ
JAMA Ophthalmol; 2014 Mar; 132(3):265-71. PubMed ID: 24435762
[TBL] [Abstract][Full Text] [Related]
15. Acquired nystagmus as the initial presenting sign of chiasmal glioma in young children.
Toledano H; Muhsinoglu O; Luckman J; Goldenberg-Cohen N; Michowiz S
Eur J Paediatr Neurol; 2015 Nov; 19(6):694-700. PubMed ID: 26190013
[TBL] [Abstract][Full Text] [Related]
16. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
[TBL] [Abstract][Full Text] [Related]
17. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
Blanchard G; Lafforgue MP; Lion-François L; Kemlin I; Rodriguez D; Castelnau P; Carneiro M; Meyer P; Rivier F; Barbarot S; Chaix Y;
Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
[TBL] [Abstract][Full Text] [Related]
18. Visual loss in orbitofacial neurofibromatosis type 1.
Oystreck DT; Morales J; Chaudhry I; Alorainy IA; Elkhamary SM; Pasha TM; Bosley TM
Ophthalmology; 2012 Oct; 119(10):2168-73. PubMed ID: 22709421
[TBL] [Abstract][Full Text] [Related]
19. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.
Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK
J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602
[TBL] [Abstract][Full Text] [Related]
20. Optic Pathway Gliomas: Clinical Manifestation, Treatment, and Follow-Up.
Ertiaei A; Hanaei S; Habibi Z; Moradi E; Nejat F
Pediatr Neurosurg; 2016; 51(5):223-8. PubMed ID: 27082859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
